Our in vitro and in vivo experiments (Fig. 2 and Supplementary Fig. 2) indicate that Cebpb-targeted cells can function in vivo as they capture and process antigens, activate T cells, and restrict tumor growth. The gene discussed is CEBPB; the disease is neoplasm.